The Therapeutic Potential of Spirulina to Combat COVID-19 Infection | ||||
| Egyptian Journal of Botany | ||||
| Article 1, Volume 60, Issue 3, December 2020, Page 605-609 PDF (886.9 K) | ||||
| Document Type: Mini Review | ||||
| DOI: 10.21608/ejbo.2020.49345.1581 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Mostafa El-Sheekh  1; Abd El-Fatah Abomohra1, 2
| ||||
| 1Botany and Microbiology Department, Faculty of Science, Tanta University, 31527 Tanta, Egypt | ||||
| 2Department of Environmental Engineering, School of Architecture and Civil Engineering, Chengdu University, Chengdu 610106, China | ||||
| Abstract | ||||
| MANY countries and labs are currently looking for a COVID-19 vaccine but have yet to explore it. Many species of Spirulina contain significant active compounds such as sulfated polysaccharides, phenols, phycobiliproteins, and calcium spirulan with inhibition activity against replication of viruses, especially influenza A (H1N1), HCV , and HIV viral infection. As there is no vaccine was approved against COVID-19, the potential of using Spirulina as antivirus and an immune agent has been tested for many viruses, and this encourages using the Spirulina as a whole amount or its extract for immunization against COVID-19, the causative pathogen of Coronavirus disease. The present article discusses some of the important studies on the therapeutic antiviral activities of the cyanobacterium Spirulina platensis. | ||||
| Keywords | ||||
| Calcium spirulan; COVID-19; Spirulina; Sulphated polysaccharides | ||||
| Full Text | ||||
|
| ||||
|
Statistics Article View: 1,449 PDF Download: 1,228 |
||||
